automated-news
Johnson & Johnson (NYSE:JNJ) Raised to “Buy” at Guggenheim
Guggenheim upgraded shares of Johnson & Johnson (NYSE:JNJ – Free Report) from a neutral rating to a buy rating in a research note published on Tuesday morning, MarketBeat reports. Guggenheim currently has $206.00 price objective on the stock, up from their pr… Read Full Article →